retatrutide clinical trial safety profile trials A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Lilly's triple agonist, retatrutide, delivered

The platform cannot make medical decisions or guarantee that any individual will receive a prescription

Experienced and compassionate medical team Science-backed, personalized treatments A holistic approach to wellness One-on-one attention and customized care Conveniently located in Jackson, WY Take the first step toward a healthier, happier you by scheduling your consultation with Dr

The trial showed positive outcomes, with up to 87% of participants reaching the target HbA1c level of 7%

If you are currently using an approved weight management medicine and experience concerning symptoms such as severe or persistent abdominal pain, persistent vomiting, a notably rapid heart rate, or signs of an allergic reaction contact your GP promptly or call NHS 111

Scalp health optimization Scalp inflammation, seborrheic dermatitis, and folliculitis can all worsen hair loss during GLP-1 therapy

It works by activating GLP-1 receptors, which help you feel fuller sooner and for longer periods, effectively reducing hunger and cravings